BioNTech Clinical Data at ELCC 2026 Highlight Potential of Differentiated Late-Stage Portfolio in Lung Cancer

GlobeNewswire

Image Credit: GlobeNewswire

Please find more details at GlobeNewswire

Summary

MAINZ, Germany, March 24, 2026BioNTech SE (Nasdaq: BNTX, BioNTech or the Company) will present data from its diversified portfolio in the field of lung cancer at the European Lung Cancer Congress (ELCC) held in Copenhagen, Denmark, from March 25-28,

Source: GlobeNewswire

Read More

(0)

Exclusive AI-Powered News Insights (For Members only)

Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!